IL6 and amyloidosis: Importantly, while previous studies have reported associations between elevated IL-6 levels and adverse outcomes in amyloidosis [27,28], our findings may have been constrained by the limited sample size, emphasizing the need for validation in larger, adequately powered cohorts.